TABAK Fair Value & Analysis
Consumer Defensive · CZ · Market cap 50.8B CZK
Fair value as of: Jul 21, 2026
From 23 valuation models · updated 20 days ago
Share price +2.0% over the past month.
A strong business, screening 26% undervalued on our models.
What matters now
- The rarer combination: high quality (85/100) AND below fair value. That earns a closer look rather than a quick verdict.
- Our model range runs from 17,411 CZK (bear) to 29,019 CZK (bull), base 23,215 CZK. The closer the price sits to the lower half, the larger the margin of safety.
- Quality 85/100 (high quality) with high evidence: the data supports the verdict.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 21, 2026.
How to read this chart
60‑month range 9,704 CZK – 19,122 CZK · fair‑value band 17,411 CZK – 29,019 CZK · the 18,480 CZK price screens below the 23,215 CZK fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 21, 2026.
Analysis
TABAK (TABAK) currently trades at 18,480 CZK, while our model-based Fair Value estimate is 23,215 CZK, implying the stock looks roughly 25.6% undervalued today. The Quality Score stands at 85/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, TABAK generated revenue of 21.7B CZK at a net margin of 14.0%. Revenue declined 2.0% year over year. It earns a return on equity of 36.3%. The stock trades on a trailing P/E of 16.7. Fundamentals as of Jul 21, 2026
Our scenario range runs from 17,411 CZK (bear case) to 29,019 CZK (bull case); at 18,480 CZK, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 3% below its 52-week high and 13% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at 2% fair-value upside, at 26%, TABAK screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 23 models by family
Widest divergence: DCF Models (39,115 CZK) versus Asset-Based (2,004 CZK). Highest evidence: Residual Income (76).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 21, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 84 · Market factors (momentum, volatility) 67
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Philip Morris CR a.s., through its subsidiary, Philip Morris Slovakia s.r.o., manufactures and markets tobacco products under the Marlboro, L&M, Philip Morris, Petra Klasik, and Sparta brands in the Czech Republic, the Slovak Republic, and internationally.
Full company description
Philip Morris CR a.s., through its subsidiary, Philip Morris Slovakia s.r.o., manufactures and markets tobacco products under the Marlboro, L&M, Philip Morris, Petra Klasik, and Sparta brands in the Czech Republic, the Slovak Republic, and internationally. It offers cigarettes and smoke-free products, including heated tobacco, e-vapor, and oral smokeless products. The company was founded in 1812 and is based in Prague, the Czech Republic. Philip Morris CR a.s. operates as a subsidiary of Philip Morris Holland Holdings B.V.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
TABAK reported revenue of 21.7B CZK in FY2025 versus 18.9B CZK in FY2021, a compound +3.5%/yr. Reported net income was 3.0B CZK in FY2025, compounding −3.6%/yr from FY2021.
Watch TABAK: get an alert when its fair value changes →
Peer Group
Tobacco · 34 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Tobacco median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Insider activity: 45/100
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Tobacco stocks, each showing price versus our Fair Value estimate (as of Jul 21, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Philip Morris International Inc PM | $188.93 | $103.71 | -45% |
| British American Tobacco p.l.c. BTI | $60.02 | $61.14 | +2% |
| Altria Group MO | $68.44 | $81.81 | +20% |
| ITC Limited ITC | ₹281.75 | ₹282.04 | +0% |
| KT&G Corporation 033780 | 179,900 KRW | 119,073 KRW | -34% |
| PT Hanjaya Mandala Sampoerna Tbk, HMSP | 695.00 IDR | 1,193 IDR | +72% |
| Godfrey Phillips India Limited GODFRYPHLP | ₹2,337 | ₹1,194 | -49% |
| PT Gudang Garam Tbk, GGRM | 16,375 IDR | 16,988 IDR | +4% |
| China Tobacco International (HK) Company 6055 | HK$23.00 | HK$24.09 | +5% |
| Universal Corporation UVV | $53.14 | $27.50 | -48% |
Compare TABAK with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is TABAK overvalued or undervalued?
What is the fair value of TABAK?
What is the quality score of TABAK?
What is the revenue of TABAK?
What is the net profit margin of TABAK?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track TABAK and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.